Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial
Stick to fresh, whole foodslean proteins, fruits, leafy greens, and healthy fats
Payers are increasingly hesitant to cover lifelong drug treatments, emphasizing the need for effective behavior change programs
Similarity network fusion for aggregating data types on a genomic scale
In summary, there is robust evidence that GLP-1 agonist therapy favorably impacts the trajectory of cardiovascular disease across the spectrum of severity
US$ 22.25
US$ 23.38
US$ 25.97
